Loading
Latest filing published 28 Feb 2020 for GlobeStar Therapeutics Corp.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Brent Atwood in GlobeStar Therapeutics Corp. The record holds 20 filings, for trades running from 13 August 2019 to 25 February 2020.
Every open-market trade on record is a purchase: 9 purchases worth €207k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
In size, the median ticket on the buying side is €13k.
On 28 February 2020 came the latest disclosure, a transaction in GlobeStar Therapeutics Corp. The last insider purchase was made public on 15 August 2019, 2,626 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations